|
1
|
Huang H, Wu D, Miao H, Tang Y, Liu C, Fang H, Meng X, Wang S, Zhu Q, Wang X, Du J, Yang Z, Li N, Xu B, He J. Accelerating the integration of China into the global development of innovative anticancer drugs. Lancet Oncol 2022; 23:e515-e520. [PMID: 36328025 DOI: 10.1016/s1470-2045(22)00483-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Revised: 07/11/2022] [Accepted: 07/15/2022] [Indexed: 11/06/2022]
|
|
2
|
Lu TP, Kamatani Y, Belbin G, Park T, Hsiao CK. Editorial: Current Status and Future Challenges of Biobank Data Analysis. Front Genet 2022; 13:882611. [PMID: 35495141 PMCID: PMC9047950 DOI: 10.3389/fgene.2022.882611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Accepted: 03/24/2022] [Indexed: 11/23/2022] Open
Affiliation(s)
- Tzu-Pin Lu
- Department of Public Health, College of Public Health, Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan
| | - Yoichiro Kamatani
- Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
| | - Gillian Belbin
- Institute of Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Taesung Park
- Department of Statistics, Seoul National University, Seoul, South Korea
| | - Chuhsing Kate Hsiao
- Department of Public Health, College of Public Health, Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan
- *Correspondence: Chuhsing Kate Hsiao,
| |
Collapse
|